¼¼°èÀÇ ´Ù¹ß¼º °æÈ­Áõ Ä¡·áÁ¦ ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : ¾à¹° Á¾·ùº°, Åõ¿© °æ·Îº°, À¯Åë ä³Îº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2025-2030³â)
Multiple Sclerosis Therapeutic Market Size, Share & Trends Analysis Report By Drug Class (Immunosuppressants, Immunostimulants), By Route Of Administration (Oral, Injectable), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030
»óǰÄÚµå : 1771503
¸®¼­Ä¡»ç : Grand View Research, Inc.
¹ßÇàÀÏ : 2025³â 06¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 150 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,950 £Ü 8,380,000
Unprintable PDF & Excel (Single User License) help
º¸°í¼­ PDF ¹× ¿¢¼¿À» 1Àθ¸ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, Àμâ´Â ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 6,950 £Ü 9,789,000
Printable PDF & Excel (5-User License) help
º¸°í¼­ PDF ¹× ¿¢¼¿À» µ¿ÀÏ ±â¾÷ ³» µ¿ÀÏ ºÎ¼­¿¡¼­ ÃÖ´ë 5¸í±îÁö »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, Àμâ´Â °¡´ÉÇÕ´Ï´Ù.
US $ 8,950 £Ü 12,606,000
Printable PDF & Excel (Enterprise License) help
º¸°í¼­ ±¸¸Å ±â¾÷ ¹× ±× ÀÚȸ»ç, °ü°è»ç°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀ̸ç, PDF ¹× ¿¢¼¿ ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, ÀμⰡ °¡´ÉÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

´Ù¹ß¼º °æÈ­Áõ Ä¡·áÁ¦ ½ÃÀå ¼ºÀå°ú µ¿Çâ:

Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é, ¼¼°è ´Ù¹ß¼º °æÈ­Áõ Ä¡·áÁ¦ ½ÃÀå ±Ô¸ð´Â 2025³âºÎÅÍ 2030³â±îÁö 5.93%ÀÇ CAGRÀ» ±â·ÏÇϸç 2030³â±îÁö 386¾ï 2,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

½ÅÈï ½ÃÀå¿¡¼­ÀÇ ³ôÀº ÀÓ»óÀû ¹ÌÃæÁ· ¼ö¿ä´Â ´Ù¹ß¼º °æÈ­Áõ Ä¡·áÁ¦ ½ÃÀåÀÇ °¡Àå ¿µÇâ·Â ÀÖ´Â ÃËÁø¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù. Àü ¼¼°è ¸¹Àº ´ÜüµéÀÌ ÁøÇ༺ ´Ù¹ß¼º °æÈ­Áõ ¹× °ü·Ã Áõ»ó¿¡ ´ëÇÑ ÀÎ½Ä °³¼±¿¡ Àû±ØÀûÀ¸·Î Âü¿©Çϰí ÀÖ½À´Ï´Ù. ¹Ì±¹ÀÇ National Multiple Sclerosis Society(NMSS), ij³ª´ÙÀÇ Multiple Sclerosis International Federation, European Multiple Sclerosis Platform(EMSP), Multiple Sclerosis Society(MSC) µîÀÌ ÀÖ½À´Ï´Ù.

»óȯ ÇÁ·Î±×·¥µµ ´Ù¹ß¼º °æÈ­Áõ Ä¡·áÁ¦ÀÇ º¸±ÞÀ» Áõ°¡½Ãų °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¾î, 2014³â 6¿ù ¹ÙÀÌ¿ÀÁ¨ ¾ÆÀ̵¦ ij³ª´Ù(Biogen Idec Canada)´Â ÀÚ»çÀÇ ´Ù¹ß¼º °æÈ­Áõ Ä¡·áÁ¦ TECFIDERA°¡ B.C. PharmaCare¸¦ ÅëÇØ ¿µ±¹ ÄÝ·Òºñ¾Æ¿¡¼­ ±Þ¿©¸¦ ¹ÞÀ» ¼ö ÀÖ°Ô µÇ¾ú´Ù°í ¹ßÇ¥ÇÏ¿´½À´Ï´Ù.

ÃÖ¼Ò ¿ë·®À¸·Î ºñ¿ë È¿À²ÀûÀÎ »õ·Î¿î Ä¡·áÁ¦ÀÇ µµÀÔÀº ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¾î, »ç³ëÇÇÀÇ ·½Æ®¶ó´Ù(Lemtrada)´Â ¸ÅÀÏ º¹¿ëÇØ¾ß ÇÏ´Â ÄÚÆÅ¼Õ(Copaxone)¿¡ ºñÇØ 1³â¿¡ 3-5ȸ¸¸ º¹¿ëÇÏ¸é µË´Ï´Ù.

´Ù¹ß¼º °æÈ­Áõ Ä¡·áÁ¦ ½ÃÀå : ºÐ¼® °³¿ä

¸ñÂ÷

Á¦1Àå ºÐ¼® ¹æ¹ý¡¤¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ´Ù¹ß¼º °æÈ­Áõ Ä¡·áÁ¦ ½ÃÀå : º¯¼ö, µ¿Çâ, ¹üÀ§

Á¦4Àå ´Ù¹ß¼º °æÈ­Áõ Ä¡·áÁ¦ ½ÃÀå : ¾à¹° Ŭ·¡½ºº° ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦5Àå ´Ù¹ß¼º °æÈ­Áõ Ä¡·áÁ¦ ½ÃÀå : Åõ¿© °æ·Îº° ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦6Àå ´Ù¹ß¼º °æÈ­Áõ Ä¡·áÁ¦ ½ÃÀå : À¯Åë ä³Îº° ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦7Àå ´Ù¹ß¼º °æÈ­Áõ Ä¡·áÁ¦ ½ÃÀå : Áö¿ªº° ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦8Àå °æÀï ±¸µµ

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Multiple Sclerosis Therapeutic Market Growth & Trends:

The global multiple sclerosis therapeutic market size is estimated to reach USD 38.62 billion by 2030, registering a CAGR of 5.93% from 2025 to 2030, according to a new report by Grand View Research, Inc. The presence of high unmet clinical needs in developing regions is one of the highest impact rendering drivers of the multiple sclerosis therapeutics market. Many organizations over the globe are actively involved in spreading awareness among people regarding progressive multiple sclerosis and the symptoms associated with it. Some notable examples include the National Multiple Sclerosis Society (NMSS) in the U.S., Multiple Sclerosis International Federation in Canada, European Multiple Sclerosis Platform (EMSP), and the Multiple Sclerosis Society (MSC).

Reimbursement programs are also anticipated to enhance the penetration of multiple sclerosis drugs. For instance, In June 2014, Biogen Idec Canada, announced that its TECFIDERA drug for the treatment of MS is available for reimbursement in British Colombia through B.C PharmaCare.

The introduction of novel therapeutics with minimal dosage requirement and cost-effectiveness is further expected to favor market growth. For, instance Lemtrada by Sanofi needs to be administered 3-5 times per year as compared to Copaxone, which requires daily administration.

Multiple Sclerosis Therapeutic Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Multiple Sclerosis Therapeutics Market Variables, Trends & Scope

Chapter 4. Multiple Sclerosis Therapeutics Market: Drug Class Estimates & Trend Analysis

Chapter 5. Multiple Sclerosis Therapeutics Market: Route of Administration Estimates & Trend Analysis

Chapter 6. Multiple Sclerosis Therapeutics Market: Distribution Channel Estimates & Trend Analysis

Chapter 7. Multiple Sclerosis Therapeutic Market: Regional Estimates & Trend Analysis

Chapter 8. Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â